Cochlear Limited
COH
Rank in Stocks
#2894
Globally, Cochlear Limited specializes in the development and provision of... Globally, Cochlear Limited specializes in the development and provision of implantable auditory solutions for both children and adults. The company's diverse offerings include advanced cochlear implant systems, upgrades for sound processors, bone conduction devices, and a wide array of accessories and other related items. Established in 1981, its global operations are directed from its headquarters in Sydney, Australia.
Share Price
$97.79
Market Cap
$6.40B
Change (1 day)
1.80%
Change (1 year)
-47.73%
Country
AU
Trade Cochlear Limited (COH)
Category
Healthcare
P/S ratio for Cochlear Limited (COH)
P/S ratio as of October 2026 TTM: 3.61
According to Cochlear Limited latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.61. At the end of 2024 the company had a P/S ratio of 9.46.
P/S ratio history for Cochlear Limited from 2000 to 2026
P/S ratio at the end of each year
| Year | P/S Ratio | Change |
|---|---|---|
| 2026 (TTM) | 3.61 | -57.02% |
| 2025 | 8.39 | -11.27% |
| 2024 | 9.46 | 21.52% |
| 2023 | 7.78 | -2.23% |
| 2022 | 7.96 | -28.16% |
| 2021 | 11.08 | 37.45% |
| 2020 | 8.06 | -4.75% |
| 2019 | 8.46 | 0.45% |
| 2018 | 8.42 | 18.89% |
| 2017 | 7.09 | 16.00% |
| 2016 | 6.11 | 23.90% |
| 2015 | 4.93 | 13.05% |
| 2014 | 4.36 | -5.51% |
| 2013 | 4.61 | -3.91% |
| 2012 | 4.80 | -4.57% |
| 2011 | 5.03 | -11.58% |
| 2010 | 5.69 | 22.72% |
| 2009 | 4.64 | 15.48% |
| 2008 | 4.02 | -32.71% |
| 2007 | 5.97 | -9.38% |
| 2006 | 6.59 | 6.80% |
| 2005 | 6.17 | 42.36% |
| 2004 | 4.33 | -26.32% |
| 2003 | 5.88 | -16.30% |
| 2002 | 7.03 | -23.43% |
| 2001 | 9.18 | 0.00% |
| 2000 | 0.00 | 0.00% |
P/S ratio for similar companies or competitors
| Company | P/S Ratio | P/S Ratio Difference | Country |
|---|---|---|---|
| 3.82 | 6.08% |
US
|
|
| 2.78 | -22.76% |
IE
|
|
| 4.18 | 15.89% |
US
|
|
| 2.97 | -17.62% |
US
|
|
| - | - |
DE
|
